Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion type Assertion NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_head.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_provenance.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion evidence source_evidence_literature NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_provenance.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion SIO_000772 14583782 NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_provenance.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion wasDerivedFrom befree-2016 NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_provenance.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion wasGeneratedBy ECO_0000203 NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_provenance.